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ABSTRACT
Aim
To provide a further insight into the usefulness of lung biopsy in children.
Methods
Lung biopsies in children from January 2007 to December 2017 were reviewed
(n=39). The histology results were categorised as: definitive diagnosis, normal lung
parenchyma, inconclusive.
Results
Lung biopsy provided a definitive diagnosis in 25 (64%) cases. A suspected
diagnosis was confirmed in 16 (41%) and a new diagnosis was found in 9 (23%)
children. Histology was inconclusive in 11 (28%) cases and normal in 3 (8%). Fifteen
(38%) of children had treatment altered due to the biopsy result.
Conclusion
Lung biopsy mostly confirmed the suspected diagnosis and was associated with a
low procedure related morbidity (n=1) and mortality (n=0). Importantly, the biopsy
result identified a pathology which altered treatment in over one third of patients.
However, in a number of cases the histology was inconclusive, therefore careful
patient selection is recommended to maximise diagnostic yield.
INTRODUCTION
Paediatric surgeons are commonly asked to carry out lung biopsies in children to
obtain tissue for a definitive histological or microbiological diagnosis. A lung biopsy is
an invasive diagnostic procedure however, often performed in children with
significant comorbidities.[1] The decision of whether to perform a lung biopsy in this
cohort of patients remains an important one, given the risks associated with the
surgery. The reported diagnostic yield from lung biopsy is variable, and its utility in
bringing a therapeutic change to patients remains largly uncertain.[1, 2] The
European protocol for Interstitial Lung Disease in Children suggests performing a
lung biopsy only if treatment will be changed as a result of the procedure.[3]
Therefore, the selection of appropriate patients is important to maximise utility and
avoid unnessessary surgical intervention in vulnerable children. This study aims to
determine the diagnostic yield of paediatric lung biopsy in our centre and provide
new data surrounding the usefulness of lung biopsy in children.
METHODS
All children who underwent diagnostic open or thoracoscopic lung biopsy in our
centre between January 2007 to December 2017 were identified from clinical coding.
All therapeutic lung resections and transbronchial lung biopsies were excluded for
the purposes of this study.
In our centre, biopsy samples underwent histological processing by a number of
different pathologists and a macroscopic and microscopic report was formulated.
Each specimen was routinely processed followed by relevant staining including
Gram, Grocott, dPAS and modified Ziehl-Neelseen to identify microorganisms within
the sample. When clinical details suggested malignancy, samples underwent
immunohistochemical staining for specific markers. In cases of significant uncertainty
or rarity, specimens were sent externally for a secondary opinion.
Patient records, histology reports and operation notes were retrospectively reviewed
for patient demographics, the indications for biopsy, preoperative investigations,
surgical technique, complications and the histological outcome. The results from lung
biopsy were categorised into three distinct groups: definitive histological diagnosis,
normal lung parenchyma, or inconclusive histology. Biopsy results were correlated
against the preoperative provisional diagnosis. Medical records were reviewed to
determine whether treatment was changed as a result of the histology results.
RESULTS
Thirty-nine patients were identified for inclusion in the study. Twenty-one were male
(53.8%) and 18 were female (46.2%). Median age at biopsy was 3.5 years (7 days –
15 years). There were 33 open procedures and six thoracoscopic (15%). Median
operative time for open biopsy was 61 mins (31-81), and for thoracoscopic biopsy
was 83 mins (30-125). The median duration of a chest drain following surgery was 2
days (1-4). The complications associated with the procedure included one child who
had a haemothorax. No persistent air leak or pneumothorax was reported in this
cohort.
Four out of the 39 lung biopsy samples were sent for a second histological review at
other specialist UK centres. In all four of these cases, the second opinion agreed
with the original decision but provided further histological detail and supplementary
information.
Lung biopsy provided a definitive histological diagnosis in 25 (64%) children, of
which a suspected diagnosis was confirmed in 16 (41%) children, and a new
diagnosis was found in 9 (23%). In the remaining children, 11 (28%) cases had a
histology result which was inconclusive and 3 (8%) had normal histology (Table 1).
Table 1: Histological results from lung biopsy
Single suspected preoperative diagnosis
CONFIRMATIVE OF SUSPECTED PREOPERATIVE DIAGNOSIS
N=2
2
Preoperative diagnosis Histology N
N=10
PTLDa PTLD 3
Pulmonary Hypertension Pulmonary Hypertension 2
Lymphangiectasis Lymphangiectasis 2
Metastasis Wilms Tumour metastasis 1
Lung dysplasia Alveolar capillary dysplasia 1
IPEXb associated pneumonia Features of immunodeficiency 1
NEW HISTOLOGICAL DIAGNOSIS
Preoperative diagnosis Histology N
N=5
Fungal infection Chronic granulomatous disease 2
Alveolar capillary dysplasia Chronic diffuse pneumonitis 1
Metastatic disease Acute haemorrhagic infarction 1
Pseudomonas infection Miliary tuberculosis 1
NORMAL LUNG PARENCHYMA
Preoperative diagnosis Histology N
N=2Parenchymal lung disease Normal 1
CPAMc Normal 1
INCONCLUSIVE HISTOLOGY
Preoperative diagnosis Histology N
N=5Infection NOS Non-specific changes 3Fungal infection Non-specific interstitial pneumonitis 1
EBVd lymphoproliferation Non-specific changes 1
Multiple preoperative differential diagnoses
CONFIRMATIVE OF A SUSPECTED PREOPERATIVE DIAGNOSIS
N=1
0
Preoperative diagnoses Histology N
N=6
PTLD/infection NOS PTLD 1
Fungal infection/Residual Lymphoma Diffuse Large B-Cell Lymphoma 1
Chemotherapy reactive lesions/Fungal
infection
Chemotherapy-related interstitial
pneumonitis 1
Fungal infection/mycobacterial infection Aspergillus infection 1
Lymphoma/Fungal
infection/Mycobacterial
Non-tuberculous mycobacterial
infection 1
Lymphoma/infection NOS Classical Hodgkin’s Lymphoma 1
NEW HISTOLOGICAL DIAGNOSIS
Preoperative diagnoses Histology N
N=1Pulmonary Hypertension/Surfactant
protein B deficiency
Pulmonary interstitial glycogenesis 1
NORMAL LUNG PARENCHYMA
Preoperative diagnoses Histology N
N=1Lymphoproliferation/Bronchiolitis
obliterans Normal 1
INCONCLUSIVE HISTOLOGY
Preoperative diagnoses Histology N
N=2Fungal infection/PTLD Non-specific thrombi related disease 1
GvHDe/Fungal infection/CMVf/TBg Non-specific pneumonitis 1
No specific preoperative diagnosis
NEW HISTOLOGICAL DIAGNOSIS
N=7
Indication for biopsy Histology N
N=3
Interstitial infiltrate on CXRh Interstitial pneumonitis 1
Respiratory condition of new-born of
unknown aetiology
Pulmonary interstitial glycogenesis 1
Persistent pulmonary infiltrates on CXR Necrotising pneumonia 1
INCONCLUSIVE HISTOLOGY
Indication for biopsy Histology N
N=4
Respiratory distress of unknown
aetiology
Mild non-specific changes 1
Unknown cause of chronic lung disease Minimal interstitial non-specific fibrosis 1
Query cause of pneumonia No specific evidence of cause 1
Abnormal CTi chest opacification Non-specific changes 1
aPost-transplant lymphoproliferative disorder, bimmunodysregulation polyendocrinopathy enteropathy X-linked syndrome, ccongenital pulmonary airway
malformation, dEpstein–Barr virus, egraft versus host disease, fcytomegalovirus, gtuberculosis, hChest x-ray, icomputerised tomography
In the cases where the histology was inconclusive, 64% had a preoperative
indication querying an infective cause. In seven children, no specific preoperative
diagnosis was stated, and in this group, 57% of histology reports were inconclusive.
When the indication for biopsy was a suspected neoplasm, a definitive diagnosis
was achieved in 90% of cases, making it the indication with the highest diagnostic
yield.
Fifteen (38%) children had their treatment altered due to the biopsy results. In these
cases, the biopsy result identified a new diagnosis or confirmed one of the several
suspected diagnoses that were queried pre-operatively, and therefore guided
management.
Thirteen (33%) of the patients died in a median of 85 days (1-666 days) post biopsy.
These deaths were not directly attributable to the surgical procedure, and rather
reflect the severe nature and complexity of such conditons which warrant a lung
biopsy. A large number of our patients had complex and rare conditions which made
them extremely sick and vulnerable. Two (5%) of our patients died within 30 days of
surgery. The first child was a 6-week old baby who died the day after the biopsy due
to legionella pneumonia with lung necrosis. The second child was a 2-week old baby
with alveolar capillary dysplasia, who died on the second postoperative day.
DISCUSSION
In our centre, lung biopsy is performed thoracoscopically for older children where
intercostal space allows 10mm trocar for the staplers. For smaller children, the
thoracotomy approach is used. CT-guided percutaneous lung biopsy has been
successful in children,[4] however, there is a significant radiation risk which must be
considered. Therefore, open or thoracoscopic lung biopsy remain the standard
procedure in our centre.
Although all specimens obtained from biopsy were suitable for histological analysis,
a definite diagnosis was reached in only 64% of cases. This is lower than some
studies, which report close to an 80% diagnosis rate.[5] This may be because a
significant proportion of our patients are immunocompromised with diffuse lung
lesions, greatly complicating their pathologies and treatments. Although morbidity
and mortality from paediatric lung biopsies are reported to be high,[2, 5] in our study
only one haemothorax was noted as a procedure-related morbidity with zero
procedure related mortality, supporting the relative safety of lung biopsy as a
diagnostic investigation.
In four cases the biopsy sample was sent externally for a second opinion. Paediatric
lung disorders form a heterogeneous group, with each individual possessing
complex and rare pathologies. In our study, although all second opinions agreed with
the original pathologists’ conclusion, they provided supplementary knowledge and
further histological detail. A nationwide approach to paediatric lung histology may
provide a higher diagnostic yield through the process of learning across specialist
centres, given the rarity of such conditions.
In our series, lung biopsy provided a definitive histological diagnosis in 64% of
cases. In 41% of cases, a preoperative suspected diagnosis was confirmed.
Therefore, if the preoperative workup is strongly suggestive of a diagnosis, an
additional lung biopsy may not be necessary. However, in 23% of children, lung
biopsy provided a new diagnosis which was not suspected preoperatively. Of this
group, 6 (67%) had a suspected pre-operative diagnosis that was proven incorrect
on biopsy, and 3 (33%) had no definitive preoperative diagnosis. In 28% of cases,
the results from lung biopsy were inconclusive which did not aid management, and
further clinical and radiological investigations were recommended. Therefore,
surgeons and paediatricians must carefully select patients for lung biopsy, especially
in groups which were shown to have a lower diagnostic yield.
CONCLUSION
In our cohort, lung biopsy mostly confirmed a suspected preoperative diagnosis and
was associated with a low procedure related morbidity (n=1) and mortality (n=0).
Importantly, the biopsy result identified a pathology which altered treatment in over
one third of patients. However, in a number of cases the histology was inconclusive.
A higher incidence of inconclusive histology was identified when the indication for
biopsy queried an infective cause or when no specific preoperative diagnosis was
stated. Therefore, careful patient selection is recommended to maximise diagnostic
yield.
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What is already known on this topic:
Lung biopsy in children is used as a diagnostic tool and is associated with significant
morbidity and mortality.
Lung biopsy is performed in children who have very serious and complicated
conditions.
The diagnostic yield of lung biopsy in children is variable and limited guidelines exist
on when to carry out this procedure.
What this study adds:
Lung biopsy results altered treatment in 38% of children.
Paediatric lung biopsy was associated with a low procedure related morbidity (n=1)
and mortality (n=0).
A higher rate of inconclusive histology was identified when looking for an infective
cause or when no specific preoperative diagnosis was stated.
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